Go Pro
NASDAQ:ANL

Adlai Nortye Q2 2026 Earnings Report

Adlai Nortye logo
$13.25 +0.39 (+3.03%)
Closing price 04:00 PM Eastern
Extended Trading
$13.20 -0.05 (-0.42%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Adlai Nortye EPS Results

Actual EPS
-$0.06
Consensus EPS
-$0.13
Beat/Miss
Beat by +$0.07
One Year Ago EPS
N/A

Adlai Nortye Revenue Results

Actual Revenue
$6.53 million
Expected Revenue
$4.72 million
Beat/Miss
Beat by +$1.81 million
YoY Revenue Growth
N/A

Adlai Nortye Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Adlai Nortye Earnings Headlines

After KDA, PRE, and OCEAN—this is the one
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage.tc pixel
Adlai Nortye: AN9025 Still Needs Human Validation
See More Adlai Nortye Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Adlai Nortye? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Adlai Nortye and other key companies, straight to your email.

About Adlai Nortye

Adlai Nortye (NASDAQ:ANL) Inc. (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control. Adlai Nortye’s global marketing and distribution network extends across Asia, Europe, North America and other regions, enabling the company to tailor products to diverse regulatory requirements and performance standards worldwide.

Since its founding in the mid-2000s, Adlai Nortye has pursued capacity expansions, new product development and strategic partnerships to strengthen its position in the fine chemicals sector. The leadership team, comprised of professionals with expertise in chemistry, engineering and international business, continues to advance initiatives designed to improve production efficiency, expand the product portfolio and enhance the company’s global market presence.

View Adlai Nortye Profile